TREATMENT OF EMPHYSEMA USING RAR SELECTIVE RETINOID AGONISTS

摘要

This invention provides methods of treating emphysema and other diseases associated with alveolar damage by treatment with an RARgamma selective agonist. In another aspect, this invention provides methods of promoting tropoelastin gene expression and alveolar matrix repair by contacting the pulmonary intestitial fibroblast with an RAR agonist, preferably an RARgamma selective agonist.